A carregar...
Recent advances in triple negative breast cancer: the immunotherapy era
BACKGROUND: Several accomplishments have been achieved in triple-negative breast cancer (TNBC) research over the last year. The phase III IMpassion130 trial comparing chemotherapy plus atezolizumab versus chemotherapy plus placebo brought breast cancer into the immunotherapy era. Nevertheless, despi...
Na minha lista:
| Publicado no: | BMC Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507064/ https://ncbi.nlm.nih.gov/pubmed/31068190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-019-1326-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|